Lv41
580 积分 2023-04-17 加入
KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells
4小时前
已完结
Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies
4小时前
已完结
Neurodegenerative diseases
1个月前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
1个月前
已完结
Usnoflast: A Cutting-Edge NLRP3 Inhibitor Attenuates Colonic Inflammation Across Diverse Immunopathology
1个月前
已完结
Recent Progress and Prospects of Small Molecules for NLRP3 Inflammasome Inhibition
1个月前
已完结
NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosis
1个月前
已完结
NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis
1个月前
已完结
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
1个月前
已完结
Inflammasomes: mechanism of assembly, regulation and signalling
1个月前
已完结